Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma
Authors
Keywords
blood-brain barrier, brain delivery, fluorescence tomography, intranasal, nanoparticle translocation
Journal
PHARMACEUTICAL RESEARCH
Volume 36, Issue 9, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-02
DOI
10.1007/s11095-019-2662-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Trigeminal Pathway Dominates the Nose-to-Brain Transportation of Intact Polymeric Nanoparticles: Evidence from Aggregation-Caused Quenching Probes
- (2019) Ye Li et al. Journal of Biomedical Nanotechnology
- Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
- (2018) Vassilis Bourganis et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
- (2018) Luigi Battaglia et al. Expert Opinion on Drug Delivery
- Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line
- (2018) Daiane Franco et al. MOLECULES
- Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
- (2018) Fabio Sonvico et al. Pharmaceutics
- Intranasal Drug Delivery of Frovatriptan Succinate Loaded Polymeric Nanoparticles for Brain Targeting
- (2018) Deepika Deepika et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
- (2018) Stella Gänger et al. Pharmaceutics
- Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents
- (2018) Teresa Musumeci et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Melatonin and Its Metabolites Ameliorate UVR-Induced Mitochondrial Oxidative Stress in Human MNT-1 Melanoma Cells
- (2018) Konrad Kleszczyński et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
- (2018) Javier Menéndez-Menéndez et al. International Journal of Endocrinology
- VPA and MEL induce apoptosis by inhibiting the Nrf2-ARE signaling pathway in TMZ-resistant U251 cells
- (2017) Hao Pan et al. Molecular Medicine Reports
- Nanomelatonin triggers superior anticancer functionality in a human malignant glioblastoma cell line
- (2017) Sanjeev Kumar Yadav et al. NANOTECHNOLOGY
- Nanoparticle transport across in vitro olfactory cell monolayers
- (2016) Oihane Gartziandia et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma
- (2016) C. Bastiancich et al. JOURNAL OF CONTROLLED RELEASE
- Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis
- (2016) Xueran Chen et al. JOURNAL OF PINEAL RESEARCH
- Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses
- (2016) Anam Khan et al. MOLECULAR PHARMACEUTICS
- Melatonergic system-based two-gene index is prognostic in human gliomas
- (2015) Gabriela S. Kinker et al. JOURNAL OF PINEAL RESEARCH
- Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium
- (2015) Alpesh Mistry et al. MOLECULAR PHARMACEUTICS
- Glioblastoma multiforme: Pathogenesis and treatment
- (2015) Constantinos Alifieris et al. PHARMACOLOGY & THERAPEUTICS
- Quantitative analysis of drug delivery to the brain via nasal route
- (2014) Luba Kozlovskaya et al. JOURNAL OF CONTROLLED RELEASE
- Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells
- (2014) Vanesa Martín et al. JOURNAL OF PINEAL RESEARCH
- Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells
- (2013) V Martín et al. BRITISH JOURNAL OF CANCER
- Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking
- (2012) Xiaopin Duan et al. Small
- Hydrogels containing redispersible spray-dried melatonin-loaded nanocapsules: a formulation for transdermal-controlled delivery
- (2012) Cristiane RD Hoffmeister et al. Nanoscale Research Letters
- Intranasal delivery of biologics to the central nervous system
- (2011) Jeffrey J. Lochhead et al. ADVANCED DRUG DELIVERY REVIEWS
- Melatonin: The smart killer
- (2011) Dave Lanoix et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
- (2011) Helgi B. Schiöth et al. MOLECULAR NEUROBIOLOGY
- Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death
- (2009) Vanesa Martín et al. CANCER LETTERS
- Biodegradable polymeric nanoparticles based drug delivery systems
- (2009) Avnesh Kumari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
- (2009) Xue Ying et al. JOURNAL OF CONTROLLED RELEASE
- Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium
- (2009) Alpesh Mistry et al. JOURNAL OF DRUG TARGETING
- Melatonin and the ovary: physiological and pathophysiological implications
- (2008) Hiroshi Tamura et al. FERTILITY AND STERILITY
- New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163
- (2008) Rintaro Hashizume et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started